Form 4 for MGNX MACROGENICS INC
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-15 · accession 0001125345-22-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-17 | 2022-06-15 | MGNX | Karrels James | SVP, CFO, Sec | P - Purchase | $2.47 | +40.0K | 191.8K | +26% | +$98.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | P | A | 40,000 | $2.47 | 191,776 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $2.435 to $2.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. (F2) Owned jointly with reporting person's wife. |